Penumbra Names Shruthi Narayan as Company President

Penumbra, the world's leading thrombectomy company, announced the promotion of Shruthi Narayan to President of the company, effective September 1, 2025. She will continue to report to Adam Elsesser, who served in the role of President before this promotion and will continue in his roles as chairman of the board and chief executive officer of Penumbra.  

"Shruthi is a dynamic, seasoned leader whose passion for innovation and proven ability to inspire global teams make her the obvious choice for this critical role," said Elsesser. "Her vision and focus on excellence will undoubtedly help sustain Penumbra's exceptional growth and market leadership, expanding access to our life-saving technology to patients around the world."

A 20-year veteran in the medical device industry, Narayan was most recently president of Penumbra's interventional business, where she led the day-to-day operations and oversaw the growth initiatives of both the company's neuro and vascular franchises. She joined Penumbra in 2013 as a product manager, starting on the stroke franchise, then transitioning to help build the peripheral vascular division, commercialising Penumbra's vascular portfolio of embolisation and thrombectomy products globally. Narayan began her medical device career at Medtronic in 2006, working in engineering, regulatory affairs and then in the cardiovascular sales organisation.